Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 66267-158

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 66267-158). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\ra\2011 Anda\orphenadrine Citrate Er Tablets\cbe (Labeling\Backup\062812\figure-01.jpg)

FDA Label Image

66267 158 20

66267 158 20
The given text seems to be a medical description including the name, strength, and composition of a medication, Orphenadrine Citrate 100mg. It also includes the product number, lot number, expiration date, serial number, and storage instructions. The text mentions that the medication is an extended-release tablet that could have side effects and warns to keep it away from children. It also provides a contact number to report side effects to the FDA and instructs to call for medical advice about side effects.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.